How have DFTX and MIRM total returns compared?

Over the past 5 years, DFTX delivered 1.43% and MIRM delivered 37.24% annualized total return. Past performance doesn't predict future results.

Definium Therapeutics, Inc. (DFTX) vs Mirum Pharmaceuticals, Inc. (MIRM)

A side-by-side comparison of Definium Therapeutics, Inc. and Mirum Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

DFTX

Definium Therapeutics, Inc.

$4.73B

$35.62HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

MIRM

Mirum Pharmaceuticals, Inc.

$4.83B

$79.25HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — DFTX vs MIRM

growth of $100 · dividends reinvested · last 7y

DFTX +24053.3% (+119.0%/yr)MIRM +516.4% (+29.7%/yr)DFTX compounded faster over this window

Log scale — wide-divergence pair

DFTX MIRM

DFTX vs MIRM: by the numbers

•MIRM is the larger company ($4.83B vs $4.73B market cap).
•Both run net losses; DFTX's is the smaller (0.00% vs -139.18% net margin).

Metrics side by side

Valuation

Metric	DFTX	MIRM
P/S ratio	N/A	7.82
P/B ratio	5.15	N/A

Profitability

Metric	DFTX	MIRM
Gross margin	0.00%	81.70%
Operating margin	0.00%	-4.25%
Net margin	0.00%	-139.18%
ROE	-38.51%	N/A
ROIC	-23.81%	-13.09%

Growth (annualized)

Metric	DFTX	MIRM
Revenue CAGR (5Y)	N/A	123.86%
Total return CAGR (5Y)	1.43%	37.24%

Frequently asked

How have DFTX and MIRM total returns compared?: Over the past 5 years, DFTX delivered 1.43% and MIRM delivered 37.24% annualized total return. Past performance doesn't predict future results.

Go deeper

Full DFTX analysis Full MIRM analysis Interactive comparison tool

Dig into the metrics

Definium Therapeutics ROE Mirum Pharmaceuticals ROE Definium Therapeutics operating margin Mirum Pharmaceuticals operating margin Definium Therapeutics revenue growth Mirum Pharmaceuticals revenue growth Definium Therapeutics free cash flow Mirum Pharmaceuticals free cash flow

Definium Therapeutics & Mirum Pharmaceuticals appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.